Clinical Trials Logo

Gynecologic Cancer clinical trials

View clinical trials related to Gynecologic Cancer.

Filter by:

NCT ID: NCT03304444 Recruiting - Post Operative Pain Clinical Trials

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

Start date: August 2016
Phase: Phase 3
Study type: Interventional

This study evaluates the comparison between liposomal bupivacaine versus bupivacaine HCl in Transversus Abdominis Plane blocks for gynecologic surgery on the length of stay in the hospital, total narcotic use, and overall complications rates.

NCT ID: NCT03302156 Terminated - Gynecologic Cancer Clinical Trials

PSMA PET and MRI in Gynecological Cancers

Start date: November 15, 2017
Phase: Phase 2
Study type: Interventional

The goal of this research is to determine the accuracy of PSMA positron emission tomography (PET) and multi-parametric magnetic resonance (MR) imaging to detect the presence of gynecological cancer cells in the body.

NCT ID: NCT03292328 Completed - Breast Cancer Clinical Trials

Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

Some types of chemotherapy used to treat breast cancer can cause damage to nerves with symptoms like tingling, numbness, muscle weakness, and pain in the hands and feet that can last and can affect functioning. The purpose of this study is to find out the effects of yoga on reducing symptoms caused by such nerve damage.

NCT ID: NCT03277469 Active, not recruiting - Gynecologic Cancer Clinical Trials

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

Start date: November 13, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to develop new tools using magnetic resonance imaging (MRI) that will improve the brachytherapy procedure and treatment for participants with gynecologic cancer.

NCT ID: NCT03260647 Recruiting - Gynecologic Cancer Clinical Trials

Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers

MAMBO
Start date: August 4, 2017
Phase:
Study type: Observational

Management of Malignant Bowel Obstruction (MBO) in Patients with Advanced Gynecological Cancers

NCT ID: NCT03258307 Completed - Gynecologic Cancer Clinical Trials

Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Omentum is adipose tissue lying under inner anterior wall Omentectomy is routine procedure in treatment of gynecological malignancy especially ovarian cancer and some advanced stage endometrial cancer. Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone secrete from adipose tissue. These regulate matabolic process. We aimed comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone levels derivated from adipose tissue pre-postoperatively in patient diagnosed with gynecological malignancy performed omentectomy or not

NCT ID: NCT03245788 Completed - Breast Cancer Clinical Trials

Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study

Start date: February 15, 2017
Phase: N/A
Study type: Interventional

The Stanford Cancer Center is undertaking a Transformation Initiative in order to improve the quality of care and care coordination across the continuum of care. The newest innovation is to introduce lay navigators to specified high-need patients. The larger goal of the project is to assess whether lay navigators can address non-clinical patient needs in a timely fashion and appropriately connect them with their clinical team when warranted. It is expected that proactive interaction with patients will decrease patient anxiety/stress related to their cancer and facilitate higher patient engagement and improved management of physical, social,and emotional health. For the pilot project, the smaller goal is to understand: how lay navigator time is used; the types and frequency of issues brought up by patients; resources that patients are given or referred to; type and frequency of mode of contact with patients; and patients' acceptance of navigators based on refusal. An electronic intake form will be used to collect this information so that data can be analyzed regularly to inform changes to the navigator program as needed.

NCT ID: NCT03207594 Active, not recruiting - Breast Cancer Clinical Trials

Improving Evidence-Based Care for Cancer Patients

Start date: September 1, 2016
Phase:
Study type: Observational

The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.

NCT ID: NCT03200639 Completed - Physical Activity Clinical Trials

Cachexia in Gynecological Cancer and the Preventive Role of Weight Training

Start date: May 30, 2015
Phase: N/A
Study type: Interventional

The study aim was to compare the effectiveness of combined training (CT; aerobic + resistance exercises) and high-intensity interval body weight training (HIITBW) on body composition, metabolic and inflammatory profile, physical function and quality of life in older women with gynecological and breast cancer and their pair-matched controls (older women with no cancer). The hypothesis of the present clinical trial is that HIITBW is effective as well as CT for improvements on body composition, metabolic and inflammatory profile, physical function and quality of life in older women with gynecological and breast cancer.

NCT ID: NCT03194347 Active, not recruiting - Gynecologic Cancer Clinical Trials

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

MAGynMA
Start date: May 29, 2017
Phase:
Study type: Observational

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the knowledge of a molecular-genetic finding affects the therapeutic decision of the physician. Furthermore, genetic changes in the tumor tissue will be compared with the changes in CTCs, DTCs and cfDNA.